Dr. Ori Rotstein is the Vice-President of Research and Innovation. He is also a Professor and Associate Chair of the Department of Surgery at the University of Toronto, as well as the former Surgeon-in-Chief at St. Michael’s Hospital and former Director of the Keenan Research Centre for Biomedical Science. He is a practicing Trauma and General Surgeon with a research interest in understanding how traumatic injury leads to alterations in the immune response of patients such that these individuals are at high risk of developing organ injury and death. He uses these insights into the mechanisms of disease to generate novel therapeutic approaches to preventing poor outcome in these patients. His work spans the “bench to bedside” continuum, wherein he investigates cellular and animal models with a view to translating these to novel therapies in humans. This translational research has led to the investigation of the use of additives in resuscitation fluids in patients sustaining such injuries.
Dr. Rotstein is an acknowledged expert in the management of intraabdominal infection and inflammation. He is the former Director of the Institute of Medical Science, University of Toronto, the postgraduate arm of the Faculty of Medicine at the University of Toronto from 2001-2011 that was responsible for graduate training programs for more than 500 MSc/PhD students. In 2012, the Institute of Medical Science honoured him with an annual lecture ‘The Ori D. Rotstein Lectureship in Translational Research’. He is a member of several prestigious medical societies including the Society of University Surgeons, the American Surgical Association, and the American Society for Clinical Investigation. He is a Past President of the Surgical Infection Society and has contributed significantly to the activities of the American College of Surgeons through his participation on the Program Committee, Surgical Forum Committee, and the Scholarship Executive Committee.
Dr. Tom Schweizer, founding director of the Neuroscience Research Program at St. Michael’s, will be taking on the role of interim director of the Keenan Research Centre for Biomedical Science. In addition to his role as director of the Neuroscience Research Program, Dr. Schweizer has been an active participant on the Executive Committee of the Keenan Research Centre and has played a critical role in the successful branding of the Keenan Research Centre over the past few years. Dr. Schweizer’s research focus is in the area of clinical neuroscience and advanced neuroimaging and he has been the recipient of multiple research awards, including an Early Researcher Award from the Ontario Ministry of Research, Innovation and Science. A full search will be undertaken later this year to identify and appoint the next permanent director of the Keenan Research Centre for Biomedical Science.
Dr. Patricia O’Campo is the Interim Executive Director of the Li Ka Shing Knowledge Institute of St. Michael’s Hospital. She holds the Chair of Intersectoral Solutions to Urban Health Problems at St. Michael’s Hospital. She is professor of Epidemiology at the Dalla Lana School of Public Health at the University of Toronto, and an adjunct professor at the Johns Hopkins Bloomberg School of Public Health. Dr. O’Campo came to St. Michael’s in 2004 and for 11 years she served as Director of the Centre for Research on Inner City Health (now MAP Centre for Urban Health Solutions). Under her leadership, the centre became nationally recognized for its policy and practice-relevant work with community partners to produce rigorous scientific methods and innovative tools aimed at improving the health of urban populations.
Dr. O’Campo’s work often focuses on upstream determinants of health, quantifying the impacts of structural issues and social programs, and working to propose concrete solutions. She established her unique approach to research even before community based participatory research was accepted as a method. Dr. O’Campo improves population well-being by createing transdisciplinary partnerships with scientists from other disciplines and with practitioners and community members from affected populations. Among her other research contributions to public health are the introduction of multilevel models in the mid 1990s, the application of concept mapping and of realist methods to health disparities research, and more recently a call for stronger evidence to support programs and interventions to address health inequities with the publication of her co-edited book, Rethinking Social Epidemiology: Toward a Science of Change (2011, Springer).
Relying mainly on primary data for her research, over the last two decades she received more than $55 million dollars as principal investigator and more than $30 million as co-investigator from national and international funding agencies to conduct a number of longitudinal studies and program evaluations in a variety of areas including mental health, intimate partner violence, children’s well-being, HIV prevention, infant mortality prevention and homelessness.
Her work has been widely recognized as evidenced by the numerous international and national career excellence awards from organizations such as the US Centers for Disease Control, American Academy of Pediatrics, American Public Health Association, & the US Institute of Medicine.
As a recognized leader in social epidemiology she has served on, and has often chaired national and international panels such as the Public Health of Canada’s Canadian Perinatal Surveillance System committee, the World Health Organization committee on Urban Health Metrics and the US National Institutes of Health Federal Advisory Committee for the multi-billion dollar National Children’s Study. She has served on local governing and advisory boards such as the Board of Directors for the United Way of Greater Toronto and York Region, the Wellesley Institute Board of Directors, and the Toronto Ward Boundary Review Advisory Board.